Searched for: subject:"non%5C%2Binsulin%5C%2Bdependent%5C%2Bdiabetes%5C%2Bmellitus"
(1 - 2 of 2)
van der Greef, J. (author), Adourian, A. (author), Muntendam, P. (author), McBurney, R.N. (author), TNO Kwaliteit van Leven (author)
Too few drug discovery projects generate a marketed drug product, often because preclinical studies fail to predict the clinical experience with a drug candidate. Improving the success of preclinical-to-clinical translation is of paramount importance in optimizing the pharmaceutical value chain. Here, we advance the case for a molecular systems...
article 2006
van der Greef, J. (author), McBurney, R.N. (author), TNO Kwaliteit van Leven (author)
The pharmaceutical industry is currently beleaguered by close scrutiny from the financial community, regulators and the general public. Productivity, in terms of new drug approvals, has generally been falling for almost a decade and the safety of a number of highly successful drugs has recently been brought into question. Here, we discuss...
article 2005